1700019G17Rik Activators represent a category of chemicals that specifically enhance the activity of the gene denoted as 1700019G17Rik in the mouse genome. The gene itself is part of the intricate network of biological coding within the mouse that dictates various cellular functions, and the activators serve to upregulate the expression or activity of this gene's product. To discover and understand these activators, a methodical approach is employed, often beginning with high-throughput screening assays. These assays rapidly evaluate numerous compounds to determine their effect on the expression of the 1700019G17Rik gene. Typically, a reporter gene system is used, wherein a readily measurable reporter-such as a fluorescent or luminescent protein-is placed under the control of the 1700019G17Rik promoter. When a compound successfully increases the activity of this promoter, a proportional increase in reporter signal is observed. Compounds that elicit a significant increase in the reporter activity are then considered possible activators of the 1700019G17Rik gene.
Following the initial screening, candidate activators undergo a battery of secondary assays to confirm and characterize their activity. Quantitative PCR (qPCR) is a pivotal technique in this phase, as it measures the amount of mRNA produced by 1700019G17Rik in response to the activators, providing a direct assessment of their impact on gene expression. Concurrently, Western blotting is employed to determine whether changes at the mRNA level translate to increased protein production. This technique allows for the detection and quantification of the 1700019G17Rik protein in cells that have interacted with the activators, and it can also reveal post-translational modifications or changes in protein stability induced by the activators. In addition to these methods, further studies can include the use of chromatin immunoprecipitation (ChIP) assays to investigate whether activators directly bind to the promoter region of 1700019G17Rik and enhance its transcriptional activity. This step is crucial for understanding the mechanism by which the compounds increase gene expression, whether by facilitating the recruitment of transcription factors or by altering the chromatin structure to a more open and accessible state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that resists degradation by phosphodiesterases. This compound mimics the action of cAMP and activates PKA, resulting in the phosphorylation of downstream targets that interact with and enhance the activity of 1700019G17Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. The increase in calcium can activate calcium-dependent kinases, such as calmodulin-dependent kinase (CaMK), which may indirectly enhance the functional activity of 1700019G17Rik by modulating proteins that interact with it. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation leads to the phosphorylation of substrates that can regulate the activity of 1700019G17Rik through downstream signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can modulate the PI3K/AKT pathway, potentially reducing negative feedback on pathways that activate 1700019G17Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK. By inhibiting p38, it may shift the cellular signaling balance, allowing for the enhancement of pathways that increase the activity of 1700019G17Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibition properties. This compound might inhibit kinases that negatively regulate pathways involving 1700019G17Rik, thus indirectly enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a lipid signaling molecule that binds to its receptors, initiating signaling cascades that can lead to the activation of signaling pathways involving 1700019G17Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium. Elevated calcium levels activate various calcium-dependent signaling pathways, which could enhance the activity of 1700019G17Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that acts as a tyrosine kinase inhibitor. By inhibiting certain tyrosine kinases, it may enhance the activity of pathways that 1700019G17Rik is involved in. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore like Ionomycin and similarly increases intracellular calcium levels to activate calcium-dependent processes that may enhance the functionality of 1700019G17Rik. | ||||||